Literature DB >> 23141119

Successful treatment of parenteral nutrition-associated liver disease in an adult by use of a fish oil-based lipid source.

Esra Venecourt-Jackson1, Simon J Hill, Russell S Walmsley.   

Abstract

Liver disease occurs in 15% to 40% of adults on long-term parenteral nutrition, with steatosis being more common than cholestasis in the adult population. This problem has been well reported in the pediatric population, but we describe the case of a man who became profoundly jaundiced after being on parenteral nutrition for 3 y and responded rapidly to a change in lipid source from soybean and olive oil-based emulsion (ClinOleic) to a fish oil-based lipid emulsion (Omegaven).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23141119     DOI: 10.1016/j.nut.2012.07.009

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

Review 1.  Redefining essential fatty acids in the era of novel intravenous lipid emulsions.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Gillian L Fell; Meredith A Baker; Kathleen M Gura; Bruce R Bistrian; Mark Puder
Journal:  Clin Nutr       Date:  2017-07-08       Impact factor: 7.324

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

3.  Fish oils in parenteral nutrition: Why could these be important for gastrointestinal oncology?

Authors:  Lynnette R Ferguson
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

4.  The relationship between the parenteral dose of fish oil supplementation and the variation of liver function tests in hospitalized adult patients.

Authors:  Maria B Badia-Tahull; Elisabet Leiva-Badosa; Ramon Jodar-Masanes; Josep Maria Ramon-Torrell; Josep Llop-Talaveron
Journal:  Nutr J       Date:  2015-07-02       Impact factor: 3.271

5.  Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.

Authors:  Alfonso Pastor-Clerigues; Ezequiel Marti-Bonmati; Javier Milara; Patricia Almudever; Julio Cortijo
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

Review 6.  Choice of Allograft in Patients Requiring Intestinal Transplantation: A Critical Review.

Authors:  Genevieve Huard; Thomas Schiano; Jang Moon; Kishore Iyer
Journal:  Can J Gastroenterol Hepatol       Date:  2017-05-03

Review 7.  New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature.

Authors:  Fotios S Fousekis; Ioannis V Mitselos; Dimitrios K Christodoulou
Journal:  Saudi J Gastroenterol       Date:  2021 Jan-Feb       Impact factor: 2.485

8.  Home parenteral nutrition with an omega-3-fatty-acid-enriched MCT/LCT lipid emulsion in patients with chronic intestinal failure (the HOME study): study protocol for a randomized, controlled, multicenter, international clinical trial.

Authors:  Stanislaw Klek; Cécile Chambrier; Sheldon C Cooper; Simon Gabe; Marek Kunecki; Loris Pironi; Farooq Rahman; Jacek Sobocki; Kinga Szczepanek; Geert Wanten; Nicole Lincke; Bernhard Glotzbach; Alastair Forbes
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

Review 9.  Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.

Authors:  Fedja A Rochling
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.